Literature DB >> 18247080

Bisphosphonate treatment in craniofacial fibrous dysplasia--a case report and review of the literature.

Antti A Mäkitie1, Jyrki Törnwall, Outi Mäkitie.   

Abstract

Fibrous dysplasia (FD) is a benign skeletal disorder which may affect one or multiple bones. Lesions often involve long bones, ribs, and craniofacial bones and cause pain, fractures, and disfigurement. We describe an adolescent girl with mandibular FD who was successfully treated with bisphosphonates. She presented with a tumor-like lesion of the mandible. During the 2-year follow-up, the lesion expanded and caused significant disfigurement and pain necessitating psychiatric support. Treatment with bisphosphonate administered intravenously resulted in rapid pain relief, normalization of bone turnover, and cosmetic improvement. Management of FD has previously consisted of either conservative follow-up or surgery depending on disease activity and localization. Based on published reports and our experience, bisphosphonates should be considered in the treatment of symptomatic cases. This line of treatment may be suitable especially for craniofacial FD in which surgical treatment is particularly challenging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247080     DOI: 10.1007/s10067-008-0842-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Spectrum and natural history of fibrous dysplasia of bone.

Authors:  Michael T Collins
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

Review 2.  Medical therapy of children with fibrous dysplasia.

Authors:  Francis H Glorieux; Frank Rauch
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

3.  Surgery of massive fibrous dysplasia and osteoma of the midface.

Authors:  M A Ragab; R H Mathog
Journal:  Head Neck Surg       Date:  1987 Mar-Apr

Review 4.  Surgical treatment of fibrous dysplasia of the cranio-maxillo-facial area. Review of the literature and personal experience form 1984 to 1999.

Authors:  R Becelli; M Perugini; G Cerulli; A Carboni; G Renzi
Journal:  Minerva Stomatol       Date:  2002 Jul-Aug

Review 5.  Craniofacial fibrous dysplasia of the fronto-orbital region: a case series and literature review.

Authors:  P Ricalde; B B Horswell
Journal:  J Oral Maxillofac Surg       Date:  2001-02       Impact factor: 1.895

Review 6.  [Craniofacial fibrous dysplasia: scan policy or surgery?].

Authors:  T D Dämmrich; F B Knapp; C C Boedeker; T Klenzner; A Berlis; W Maier; J Schipper
Journal:  Laryngorhinootologie       Date:  2006-11-27       Impact factor: 1.057

7.  Fronto-orbital fibrous dysplasia.

Authors:  Reha Yavuzer; Henry Bone; Ian T. Jackson
Journal:  Orbit       Date:  2000-06

8.  Treatment of monostotic fibrous dysplasia with pamidronate.

Authors:  Marcin Kos; Klaudiusz Luczak; Jan Godzinski; Jan Klempous
Journal:  J Craniomaxillofac Surg       Date:  2004-02       Impact factor: 2.078

9.  Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases.

Authors:  Brendan Chan; Margaret Zacharin
Journal:  J Clin Endocrinol Metab       Date:  2006-03-21       Impact factor: 5.958

Review 10.  Osteonecrosis of the jaw related to the use of bisphosphonates.

Authors:  Tim Van den Wyngaert; Manon T Huizing; Jan B Vermorken
Journal:  Curr Opin Oncol       Date:  2007-07       Impact factor: 3.645

View more
  11 in total

1.  Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.

Authors:  A Sokal; E Elefant; T Leturcq; D Beghin; X Mariette; R Seror
Journal:  Osteoporos Int       Date:  2018-08-31       Impact factor: 4.507

2.  Surgical treatment of polyostotic craniomaxillofacial fibrous dysplasia in adult: a case report and review of the literature.

Authors:  Jinzhong Li; Hua Li; Xiaoyong Liu; Zhengxue Han
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Fibrous dysplasia: an overview of disease process, indications for surgical management, and a case report.

Authors:  Oluwaseun A Adetayo; Samuel E Salcedo; Vedant Borad; Sara S Richards; Adrienne D Workman; Andrea O Ray
Journal:  Eplasty       Date:  2015-02-26

Review 4.  Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders.

Authors:  Taha Faruqi; Naveen Dhawan; Jaya Bahl; Vineet Gupta; Shivani Vohra; Khin Tu; Samir M Abdelmagid
Journal:  Biomed Res Int       Date:  2014-10-22       Impact factor: 3.411

5.  Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia.

Authors:  Chiara Di Pede; Sabrina Congedi; Sara Rossin; Antuan Divisic; Alesandra De Gregorio; Caterina Agosto; Igor Catalano; Alessandro Mazza; Leonardo Sartori; Stefano Masiero; Franca Benini
Journal:  Case Rep Pediatr       Date:  2016-09-22

Review 6.  Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Authors:  Marlous Rotman; Neveen Agnes Therese Hamdy; Natasha M Appelman-Dijkstra
Journal:  Br J Clin Pharmacol       Date:  2018-12-25       Impact factor: 4.335

7.  Pain in fibrous dysplasia: relationship with anatomical and clinical features.

Authors:  Bas C J Majoor; Eva Traunmueller; Werner Maurer-Ertl; Natasha M Appelman-Dijkstra; Andrea Fink; Bernadette Liegl; Neveen A T Hamdy; P D Sander Dijkstra; Andreas Leithner
Journal:  Acta Orthop       Date:  2019-04-30       Impact factor: 3.717

8.  Fibrous dysplasia and cherubism.

Authors:  Surajit Bhattacharya; R K Mishra
Journal:  Indian J Plast Surg       Date:  2015 Sep-Dec

9.  New therapeutic targets in rare genetic skeletal diseases.

Authors:  Michael D Briggs; Peter A Bell; Michael J Wright; Katarzyna A Pirog
Journal:  Expert Opin Orphan Drugs       Date:  2015-09-24       Impact factor: 0.694

10.  Recurrent Monostotic Fibrous Dysplasia in the Mandible.

Authors:  Nilton Alves; Reinaldo José de Oliveira; Denise Takehana; Naira Figueiredo Deana
Journal:  Case Rep Dent       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.